Erratum to: Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Neuro-Oncology 2026 Open access

Read full text

DOI: 10.1093/neuonc/noag031

Cited by: 0

Fields of Study & Subjects

Glioma Diagnosis and Treatment Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research